Bharat Biotech's Intranasal COVID-19 Booster Vaccine Gets Approval
The Centre has approved Bharat Biotech's needle-free intranasal COVID-19 vaccine for booster dose, reports an official source.
The nasal vaccine has been approved for those aged above 18 years. The vaccine will be available in the private hospitals for booster dose in the initial phase.
Intranasal Vaccine to Fight COVID-19
The source said that the nasal vaccine will be used as a heterologous booster among the eligible population. Meanwhile, the intranasal COVID-19 vaccine is also expected to be introduced in the COVID-19 vaccination program, said the source.‘Bharat Biotech's intranasal COVID-19 vaccine will be available in the private hospitals for booster dose in the initial phase.’
The nasal vaccine is likely to be added to the CoWIN App from this day only.
Meanwhile, India reported 163 fresh COVID-19 cases along with nine deaths have also been reported in the country. The number of active coronavirus cases declined to 3,380.
Source: IANS